Table of Content

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Transplant Drug Monitoring Assay Market

4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, 2017–2031

5. Key Insights
5.1. Pricing Analysis of Drugs (Tacrolimus, Methotrexate and Cyclosporin)
5.2. Volume Units of Transplant Drugs in 2018-2021 (Tacrolimus, Methotrexate and Cyclosporin)
5.3. Key Industry Events (mergers, acquisitions, partnerships, collaborations, etc.)
5.4. COVID-19 Pandemic Impact on Industry (value chain and short/mid/long-term impact)

6. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Product, 2017–2031
6.3.1. Consumables
6.3.2. Equipment
6.3.2.1. Immunoassay Analyzers
6.3.2.2. Chromatography & MS Detectors
6.3.2.3. Clinical Chemistry Analyzers
6.4. Market Attractiveness Analysis, By Product

7. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, By Drug
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Drug, 2017–2031
7.3.1. Tacrolimus
7.3.2. Methotrexate
7.3.3. Cyclosporin
7.3.4. Others
7.4. Market Attractiveness Analysis, By Drug

8. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, By Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Technology , 2017–2031
8.3.1. Immunoassays
8.3.2. Chromatography-MS
8.3.3. Others
8.4. Market Attractiveness Analysis, By Technology

9. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospital Laboratories
9.3.2. Commercial & Private Laboratories
9.3.3. Others
9.4. Market Attractiveness Analysis, By End-user

10. Global Transplant Drug Monitoring Assay Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, By Region

11. North America Transplant Drug Monitoring Assay Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product, 2017–2031
11.2.1. Consumables
11.2.2. Equipment
11.2.2.1. Immunoassay Analyzers
11.2.2.2. Chromatography & MS Detectors
11.2.2.3. Clinical Chemistry Analyzers
11.3. Market Value Forecast, by Drug, 2017–2031
11.3.1. Tacrolimus
11.3.2. Methotrexate
11.3.3. Cyclosporin
11.3.4. Others
11.4. Market Value Forecast, by Technology, 2017–2031
11.4.1. Immunoassays
11.4.2. Chromatography-MS
11.4.3. Others
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospital Laboratories
11.5.2. Commercial & Private Laboratories
11.5.3. Others
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Drug
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country

12. Europe Transplant Drug Monitoring Assay Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product, 2017–2031
12.2.1. Consumables
12.2.2. Equipment
12.2.2.1. Immunoassay Analyzers
12.2.2.2. Chromatography & MS Detectors
12.2.2.3. Clinical Chemistry Analyzers
12.3. Market Value Forecast, by Drug, 2017–2031
12.3.1. Tacrolimus
12.3.2. Methotrexate
12.3.3. Cyclosporin
12.3.4. Others
12.4. Market Value Forecast, by Technology, 2017–2031
12.4.1. Immunoassays
12.4.2. Chromatography-MS
12.4.3. Others
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospital Laboratories
12.5.2. Commercial & Private Laboratories
12.5.3. Others
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Drug
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country/Sub-region

13. Asia Pacific Transplant Drug Monitoring Assay Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product, 2017–2031
13.2.1. Consumables
13.2.2. Equipment
13.2.2.1. Immunoassay Analyzers
13.2.2.2. Chromatography & MS Detectors
13.2.2.3. Clinical Chemistry Analyzers
13.3. Market Value Forecast, by Drug, 2017–2031
13.3.1. Tacrolimus
13.3.2. Methotrexate
13.3.3. Cyclosporin
13.3.4. Others
13.4. Market Value Forecast, by Technology, 2017–2031
13.4.1. Immunoassays
13.4.2. Chromatography-MS
13.4.3. Others
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospital Laboratories
13.5.2. Commercial & Private Laboratories
13.5.3. Others
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Drug
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Transplant Drug Monitoring Assay Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product, 2017–2031
14.2.1. Consumables
14.2.2. Equipment
14.2.2.1. Immunoassay Analyzers
14.2.2.2. Chromatography & MS Detectors
14.2.2.3. Clinical Chemistry Analyzers
14.3. Market Value Forecast, by Drug, 2017–2031
14.3.1. Tacrolimus
14.3.2. Methotrexate
14.3.3. Cyclosporin
14.3.4. Others
14.4. Market Value Forecast, by Technology , 2017–2031
14.4.1. Immunoassays
14.4.2. Chromatography-MS
14.4.3. Others
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospital Laboratories
14.5.2. Commercial & Private Laboratories
14.5.3. Others
14.6. Market Value Forecast, by Country/Sub-region, 2017–2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Drug
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Transplant Drug Monitoring Assay Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product, 2017–2031
15.2.1. Consumables
15.2.2. Equipment
15.2.2.1. Immunoassay Analyzers
15.2.2.2. Chromatography & MS Detectors
15.2.2.3. Clinical Chemistry Analyzers
15.3. Market Value Forecast, by Drug, 2017–2031
15.3.1. Tacrolimus
15.3.2. Methotrexate
15.3.3. Cyclosporin
15.3.4. Others
15.4. Market Value Forecast, by Technology , 2017–2031
15.4.1. Immunoassays
15.4.2. Chromatography-MS
15.4.3. Others
15.5. Market Value Forecast, by End-user, 2017–2031
15.5.1. Hospital Laboratories
15.5.2. Commercial & Private Laboratories
15.5.3. Others
15.6. Market Value Forecast, by Country/Sub-region, 2017–2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Drug
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country/Sub-region

16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company, 2021
16.3. Company Profiles
16.3.1. Abbott
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Company Financials
16.3.1.3. Growth Strategies
16.3.1.4. SWOT Analysis
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Company Financials
16.3.2.3. Growth Strategies
16.3.2.4. SWOT Analysis
16.3.3. H.U. Group Holdings Inc. (Fujirebio Holdings, Inc.)
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Company Financials
16.3.3.3. Growth Strategies
16.3.3.4. SWOT Analysis
16.3.4. Hoffmann-La Roche Ltd.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Company Financials
16.3.4.3. Growth Strategies
16.3.4.4. SWOT Analysis
16.3.5. Siemens Healthineers AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Company Financials
16.3.5.3. Growth Strategies
16.3.5.4. SWOT Analysis
16.3.6. Hologic, Inc.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Company Financials
16.3.6.3. Growth Strategies
16.3.6.4. SWOT Analysis
16.3.7. Danaher Corporation
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Company Financials
16.3.7.3. Growth Strategies
16.3.7.4. SWOT Analysis
16.3.8. Bio-Rad Laboratories, Inc.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Company Financials
16.3.8.3. Growth Strategies
16.3.8.4. SWOT Analysis



List of Figures

List of Figures

Figure 01: Global Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 02: Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 03: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Consumables, 2017–2031

Figure 04: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Equipment, 2017–2031

Figure 05: Global Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 06: Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 07: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Immunoassays, 2017–2031

Figure 08: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Chromatography-MS, 2017–2031

Figure 09: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Others, 2017–2031

Figure 10: Global Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 11: Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 12: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Tacrolimus, 2017–2031

Figure 13: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Methotrexate, 2017–2031

Figure 14: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Cyclosporin, 2017–2031

Figure 15: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Others, 2017–2031

Figure 16: Global Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 17: Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 18: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Hospital Laboratories, 2017–2031

Figure 19: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Commercial & Private Laboratories, 2017–2031

Figure 20: Global Transplant Drug Monitoring (TDM) Assay Market (US$ Mn), by Others, 2017–2031

Figure 21: Global Transplant Drug Monitoring (TDM) Assay Market, by Region, 2021 and 2031

Figure 22: Global Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Region, 2022–2031

Figure 23: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031

Figure 24: North America Transplant Drug Monitoring (TDM) Assay Market, by Country, 2021 and 2031

Figure 25: North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country, 2022–2031

Figure 26: North America Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 27: North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 28: North America Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 29: North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 30: North America Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 31: North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 32: North America Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 33: North America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 34: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031

Figure 35: Europe Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031

Figure 36: Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 37: Europe Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 38: Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 39: Europe Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 40: Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 41: Europe Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 42: Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 43: Europe Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 44: Europe Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 45: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031

Figure 46: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region/Sub-region, 2021 and 2031

Figure 47: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 48: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 49: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 50: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 51: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 52: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 53: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 54: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 55: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 56: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031

Figure 57: Latin America Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031

Figure 58: Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 59: Latin America Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 60: Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 61: Latin America Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 62: Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 63: Latin America Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 64: Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 65: Latin America Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 66: Latin America Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 67: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, 2017–2031

Figure 68: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Country/Sub-region, 2021 and 2031

Figure 69: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Country/Sub-region, 2022–2031

Figure 70: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Product, 2021 and 2031

Figure 71: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Product, 2022–2031

Figure 72: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Technology, 2021 and 2031

Figure 73: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Technology, 2022–2031

Figure 74: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by Drug, 2021 and 2031

Figure 75: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by Drug, 2022–2031

Figure 76: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market, by End-user, 2021 and 2031

Figure 77: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Attractiveness Analysis, by End-user, 2022–2031

Figure 78: Global Transplant Drug Monitoring (TDM) Assay Market Share Analysis/Ranking, by Company, 2021

List of Tables

List of Tables

Table 01: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 03: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 04: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 05: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country, 2017–2031

Table 08: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 10: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 11: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 12: North America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 16: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 17: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 18: Europe Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 21: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 22: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 23: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 24: Asia Pacific Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 27: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 28: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 29: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 30: Latin America Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 33: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Equipment, 2017–2031

Table 34: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Technology, 2017–2031

Table 35: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by Drug, 2017–2031

Table 36: Middle East & Africa Transplant Drug Monitoring (TDM) Assay Market Value (US$ Mn) Forecast, by End-user, 2017–2031